相关实验视频
Updated: Jul 25, 2025

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.5K
开发和验证利维体病护理人员活动规模的发展和验证
Kelly E Stacy1, Joshua Lambert2, Rhonna Shatz3
1University of Cincinnati College of Nursing, Cincinnati, OH, USA sumpteke@mail.uc.edu.
Journal of nursing measurement
|June 23, 2023
概括
照顾患有莱维体病 (LBD) 的人是一项挑战. 新的LBD护理人员活动量表 (LBD-CAS) 证明了对评估护理人员活动的有效性.
科学领域:
- 神经学 神经学
- 老年学是一门学科.
- 护理人员支持护理人员支持
背景情况:
- 莱维体病 (LBD) 给护理人员带来了重大挑战.
- 为LBD护理人员开发有效的评估工具至关重要.
研究的目的:
- 开发和验证莱维体病护理人员活动量表 (LBD-CAS).
- 评估LBD-CAS.的内容和面部有效性.
主要方法:
- 规模的发展由护理人员采访提供信息.
- 通过专家审查 (I-CVI) 评估的内容有效性.
- 面部有效性由家庭护理人员评估.
主要成果:
- 49项物品获得了0.83或更高的专家I-CVI分数;整体范围的CVI为0.86.
- 保留了四个具有较低I-CVI的概念意义的项目.
- 护理人员的评估表明好的项目可变性,没有显著的天花板/地板效应.
结论:
- LBD-CAS为测量LBD护理人员活动提供了内容和面部有效性的证据.
- 该尺度是评估对LBD护理人员的需求的一个有希望的工具.
- 建议对LBD-CAS进行进一步的心理测量验证.
相关概念视频
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
1.6K
The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
1.6K
Parkinson's Disease: Overview
607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607

